BLEEDING RISK AMONG JAPANESE NON-VALVULAR ATRIAL FIBRILLATION PATIENTS INITIATED ON APIXABAN, DABIGATRAN, RIVAROXABAN OR WARFARIN IN THE REAL WORLD

被引：1
|
作者：
Wang, Feng
Murata, Tatsunori
Izumi, Naoko
Kida, Makoto
Horblyuk, Ruslan
Terayama, Yasuo
机构：
[1] Bristol Myers Squibb Co, Princeton, NJ USA
[2] Pfizer, New York, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2017年 / 69卷 / 11期
关键词：
D O I：
10.1016/S0735-1097(17)33832-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1189-090
引用
收藏
页码：443 / 443
页数：1
相关论文
共 50 条
  • [41] Risk of stroke/systemic embolism, major bleeding, and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran, or rivaroxaban compared with warfarin in the United States medicare population: updated analysis
    Amin, Alpesh
    Keshishian, Allison
    Hines, Dionne M.
    Dina, Oluwaseyi
    Le, Hannah
    Rosenblatt, Lisa
    Liu, Xianchen
    Zhang, Qisu
    Vo, Lien
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (12) : 2131 - 2140
  • [42] A Comparative Study of the Clinical Benefits of Rivaroxaban and Warfarin in Patients With Non-valvular Atrial Fibrillation With High Bleeding Risk
    Liu, Peng-Hui
    Liu, Ze-Hua
    Niu, Ming-Hui
    Chen, Ping
    Shi, Yuan-Bin
    He, Fei
    Guo, Rong
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [43] Real world comparison of major bleeding risk among nonvalvular atrial fibrillation patients newly initiated on apixaban, warfarin, dabigatran or rivaroxaban: a 1:1 propensity-score matched analysis
    Lip, Gregory
    Keshishian, Allison
    Kamble, Shital
    Pan, Xianying
    Burns, Leah
    Mardekian, Jack
    Masseria, Cristina
    Bruno, Amanda
    Phatak, Hemant
    [J]. PHARMACOTHERAPY, 2016, 36 (12): : E213 - E213
  • [44] Network meta-analysis of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation
    Marx, S.
    Diener, H. -C.
    Harenberg, J.
    Lip, G.
    Marder, V.
    Wehling, M.
    Weiss, C.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 815 - 815
  • [45] The risk of acute kidney injury in Asians treated with apixaban, rivaroxaban, dabigatran, or warfarin for non-valvular atrial fibrillation: A nationwide cohort study in Taiwan
    Chan, Yi-Hsin
    Yeh, Yung-Hsin
    Hsieh, Mei-Yun
    Chang, Chia-Yu
    Tu, Hui-Tzu
    Chang, Shang-Hung
    See, Lai-Chu
    Kuo, Chang-Fu
    Kuo, Chi-Tai
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 265 : 83 - 89
  • [46] REAL WORLD DISCONTINUATION RATES WITH APIXABAN VERSUS WARFARIN, DABIGATRAN, OR RIVAROXABAN AMONG ATRIAL FIBRILLATION PATIENTS NEWLY INITIATED ON ANTICOAGULATION THERAPY: EARLY FINDINGS
    Pan, Xianying
    Kachroo, Sumesh
    Liu, Xianchen
    Kawabata, Hugh
    Phatak, Hemant
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A415 - A415
  • [47] Cost-effectiveness of Apixaban Against Dabigatran and Rivaroxaban for Stroke Prevention in Non-valvular Atrial Fibrillation Patients
    Lip, Gregory Y.
    Lanitis, Tereza
    Kongnakorn, Thitima
    Phatak, Hemant
    Liu, Larry Z.
    Lawrence, John
    Dorian, Paul
    [J]. CIRCULATION, 2014, 130
  • [48] Clinical Impact of Switching or Continuation of Apixaban or Rivaroxaban among Patients with Non-Valvular Atrial Fibrillation
    Deitelzweig, Steven
    Kang, Amiee
    Jiang, Jenny
    Gao, Chuan
    Luo, Xuemei
    Atreja, Nipun
    Han, Stella
    Cheng, Dong
    Loganathan, Saarusri R.
    Lip, Gregory Y. H.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (04)
  • [49] Clinical impact of switching or continuation of apixaban or rivaroxaban among patients with non-valvular atrial fibrillation
    Deitelzweig, S.
    Kang, A.
    Jiang, J.
    Gao, C.
    Luo, X.
    Atreja, N.
    Han, S.
    Cheng, D.
    Lip, G.
    [J]. EUROPEAN HEART JOURNAL, 2023, 44
  • [50] COST EFFECTIVENESS OF ORAL ANTICOAGULATION THERAPY FOR NON-VALVULAR ATRIAL FIBRILLATION PATIENTS: WARFARIN VERSUS THE NEW ORAL ANTICOAGULANTS RIVAROXABAN, DABIGATRAN AND APIXABAN
    Ortiz-Cartagena, Ismael
    Gotay, Antonio Orraca
    Acevedo, Jose
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 490 - 490
12345